Ушбу ишга иқтибос қилган ишлар

5 та иш

Иш: TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation <i>in vitro</i> and <i>in vivo</i>

1. The characterisation, pharmacokinetic and tissue distribution studies of TPGS modified myricetrin mixed micelles in rats

   Chunmei Wei, Qilong Wang, Wen Weng +7

   МақолаDrug Transport and Resistance MechanismsJournal of Microencapsulation201911 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.080826

2. Preparation, characterization, pharmacokinetics and anti-hyperuricemia activity studies of myricitrin-loaded proliposomes

   Wen Weng, Qilong Wang, Chunmei Wei +8

   МақолаGout, Hyperuricemia, Uric AcidInternational Journal of Pharmaceutics201911 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.080829

3. Preparation, in vitro and in vivo evaluation of isoliquiritigenin-loaded TPGS modified proliposomes

   Jian Liu, Qilong Wang, Michael Adu‐Frimpong +9

   МақолаPharmacological Effects of Natural CompoundsInternational Journal of Pharmaceutics20196 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000070

4. Improved oral bioavailability and target delivery of 6-shogaol via vitamin E TPGS-modified liposomes: Preparation, in-vitro and in-vivo characterizations

   Rui Bao, Qilong Wang, Ran Li +5

   МақолаGinger and Zingiberaceae researchJournal of Drug Delivery Science and Technology20202 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000091

5. Preparation, <i>in vitro</i> and <i>in vivo</i> evaluation of pinocembrin-loaded TPGS modified liposomes with enhanced bioavailability and antihyperglycemic activity

   Xinyi Shen, Wanjing Rong, Michael Adu‐Frimpong +10

   МақолаNanoparticle-Based Drug DeliveryDrug Development and Industrial Pharmacy20221 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.000445